Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

564 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship.
Bhatt NB, Baudin E, Meggi B, da Silva C, Barrail-Tran A, Furlan V, Grinsztejn B, Bonnet M, Taburet AM; ANRS 12146/12214-CARINEMO Study Group. Bhatt NB, et al. Among authors: grinsztejn b. J Antimicrob Chemother. 2015 Jan;70(1):225-32. doi: 10.1093/jac/dku348. Epub 2014 Sep 18. J Antimicrob Chemother. 2015. PMID: 25239466 Free PMC article.
The DART trial: 'The doctor's dilemma' revisited.
Nunes EP, Grinsztejn B, Schechter M. Nunes EP, et al. Among authors: grinsztejn b. J Antimicrob Chemother. 2011 May;66(5):964-7. doi: 10.1093/jac/dkr020. Epub 2011 Feb 15. J Antimicrob Chemother. 2011. PMID: 21393146 Clinical Trial.
Randomized clinical trial comparing the pharmacokinetics of standard- and increased-dosage lopinavir-ritonavir coformulation tablets in HIV-positive pregnant women.
Santini-Oliveira M, Estrela Rde C, Veloso VG, Cattani VB, Yanavich C, Velasque L, Torres TS, Marins LM, Pilotto JH, João EC, Gonçalves JC, Grinsztejn B. Santini-Oliveira M, et al. Among authors: grinsztejn b. Antimicrob Agents Chemother. 2014 May;58(5):2884-93. doi: 10.1128/AAC.02599-13. Epub 2014 Mar 10. Antimicrob Agents Chemother. 2014. PMID: 24614377 Free PMC article. Clinical Trial.
Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income country.
Santiago P, Grinsztejn B, Friedman RK, Cunha CB, Coelho LE, Luz PM, de Oliveira AV, Moreira RI, Cardoso SW, Veloso VG, Suassuna JH. Santiago P, et al. Among authors: grinsztejn b. PLoS One. 2014 Apr 3;9(4):e93748. doi: 10.1371/journal.pone.0093748. eCollection 2014. PLoS One. 2014. PMID: 24699873 Free PMC article.
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.
Grinsztejn B, De Castro N, Arnold V, Veloso VG, Morgado M, Pilotto JH, Brites C, Madruga JV, Barcellos NT, Santos BR, Vorsatz C, Fagard C, Santini-Oliveira M, Patey O, Delaugerre C, Chêne G, Molina JM; ANRS 12 180 Reflate TB study group. Grinsztejn B, et al. Lancet Infect Dis. 2014 Jun;14(6):459-67. doi: 10.1016/S1473-3099(14)70711-X. Epub 2014 Apr 9. Lancet Infect Dis. 2014. PMID: 24726095 Clinical Trial.
The future role of CD4 cell count for monitoring antiretroviral therapy.
Ford N, Meintjes G, Pozniak A, Bygrave H, Hill A, Peter T, Davies MA, Grinsztejn B, Calmy A, Kumarasamy N, Phanuphak P, deBeaudrap P, Vitoria M, Doherty M, Stevens W, Siberry GK. Ford N, et al. Among authors: grinsztejn b. Lancet Infect Dis. 2015 Feb;15(2):241-7. doi: 10.1016/S1473-3099(14)70896-5. Epub 2014 Nov 19. Lancet Infect Dis. 2015. PMID: 25467647 Review.
Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study.
Luetkemeyer AF, Rosenkranz SL, Lu D, Grinsztejn B, Sanchez J, Ssemmanda M, Sanne I, McIlleron H, Havlir DV, Haas DW; Adult AIDS Clinical Trials Group A5221 and A5243 Study Teams. Luetkemeyer AF, et al. Among authors: grinsztejn b. Clin Infect Dis. 2015 Jun 15;60(12):1860-3. doi: 10.1093/cid/civ155. Epub 2015 Feb 26. Clin Infect Dis. 2015. PMID: 25722197 Free PMC article.
564 results